Pleasantville, NY, United States of America

Carolina Bigarella

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shy Therapeutics LLC. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carolina Bigarella: Innovator in Cancer Treatment

Introduction

Carolina Bigarella is a prominent inventor based in Pleasantville, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various diseases.

Latest Patents

Carolina holds 1 patent for her innovative work on "Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease." This patent includes compounds of Formula I, or a pharmaceutically acceptable form thereof, and pharmaceutical compositions comprising the same. Additionally, she has outlined methods for modulating the activity of cellular targets by administering these compounds to subjects. Her research also provides methods for treating cancer, fibrotic diseases, and inflammatory diseases.

Career Highlights

Carolina has established herself as a key figure in her field, working diligently to advance medical treatments through her research and inventions. Her work has the potential to impact the lives of many individuals suffering from serious health conditions.

Collaborations

Carolina collaborates with Yaron R Hadari, enhancing her research efforts and contributing to the development of innovative solutions in the pharmaceutical industry.

Conclusion

Carolina Bigarella's contributions to cancer treatment and her innovative approach to pharmaceutical compounds highlight her importance in the field of medical research. Her work continues to pave the way for advancements in treating complex diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…